Orbis argues the old emerging markets playbook no longer fits current realities. The paper highlights cheaper valuations, improving reforms, and a broader opportunity set than headline narratives suggest. It also makes the case that investor skepticism may be overlooking a market trading at a roughly 60% discount to the US.
Emerging Markets: The Map Is Not the Terrain
Orbis Investments
Research
18 Pages
Key Takeaways
Valuation Gap Is Wide: Emerging markets trade at about 16x earnings versus 38x for US equities.
Reforms Are Becoming Tangible: Samsung Electronics announced a ₩10 trillion buyback in 2024 to support valuation.
Diversification Still Helps: Emerging markets show a 0.66 correlation with US equities since 1988.